Remote monitoring for active cardiovascular implantable electronic devices: A European survey

Abstract

This survey sampled today's European practices in the use of remote monitoring (RM) for the follow-up of active cardiovascular implantable electronic devices. Eighty-five per cent of the responding centres are currently using RM. For the majority, RM is expected to increase importantly within 5 years, and it has already led to a new organization of care based on dedicated allied professionals and/or the creation of RM units. There are still major limitations for the development of RM, such as ethical and legal aspects, reimbursement issues, and the lack of specific national-and European-updated guidelines which need to be informed. Published on behalf of the European Society of Cardiology. © 2010 The Author.